Outsourced Pharma App Notes & Case Studies
-
Accelerating Bulk Harvest Testing Using A CHO Animal Origin Free Virus Panel
10/19/2023
Here, we describe the design and performance of a degenerate PCR-based approach to broad virus screening that can be used in testing bulk harvest material derived from CHO cells.
-
Explore Protein Interactions Beyond Affinity To Boost Your Academic Research
7/20/2022
Explore how you can simplify research on protein-protein interactions using our SPR systems.
-
Development Of A Novel Cell Culture Medium For AAV Production
9/26/2023
Explore the medium development process of a novel cell culture medium for AAV production with multiple HEK293 lineages, which was performed with three different HEK293 cell lines to maximize AAV titers.
- Bulk Filling Of Drug Substance | Accurate Aliquoting 4/24/2024
-
Enhancing Ease Of Use Batch Turnaround And Process Flexibility With Single-Use TFF
6/17/2022
Use of single-use Pellicon® Capsules is an effective strategy for improving operational flexibility, product safety, and turnaround of a TFF step.
-
Cell Line Development For High-Titer Lentivirus Vector Production
3/21/2024
Explore a groundbreaking method to significantly enhance LV vector yield using engineered HEK293T cells. This approach paves the way for more efficient and large-scale production of LV vectors.
-
Empty/Full Capsid Ratio Of AAV By Sedimentation Velocity – Analytical Ultracentrifugation
9/29/2022
AAV capsids have the potential to impact safety and efficacy. Here we learn more about the results generated from an internal study using AAV8 capsids.
-
Integrating Early-Phase Clinical Supply Manufacturing & Distribution
5/10/2022
A tablet formulation was a solution when developing a new class of anti-infective medicine, allowing the integration of formulation development, clinical trial material (CTM) manufacturing, and supply and distribution to patients.
-
Protein L Affinity Resin Is Ready To Move To Manufacturing
7/12/2023
Discover a protein L affinity chromatography resin that is well suited for use in biomanufacturing and offers increased binding capacities compared to other resins.
-
Optimizing Recovery On The Sepax™ Cell Processing System
7/21/2022
Using a model T-cell line, we demonstrate the impact of varying rinse volume, intermediate volume, and manual extraction parameters on overall cell recovery with a final product dose volume of 20 mL.